SUBRAMANIAN NALLASIVAN

SUBRAMANIAN NALLASIVAN

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2022 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
KMKavitha Mohanasundaram
Kavitha Mohanasundaram
SSSham Santhanam
Sham Santhanam
RNRaja Natarajan
Raja Natarajan
HMHema Murugesan
Hema Murugesan
TNThilagavathy Nambi
Thilagavathy Nambi
SNSUBRAMANIAN NALLASIVAN
SUBRAMANIAN NALLASIVAN

16 March 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
HMHafis Muhammed
Hafis Muhammed
AJAvinash Jain
Avinash Jain
MIMohammad Irfan
Mohammad Irfan
SCSheba Charles
Sheba Charles
PDPreksha Dwivedi
Preksha Dwivedi
FIFor The Sle-Sig Of Ira
For The Sle-Sig Of Ira

1 June 2011 in Journal of the Royal College of Physicians of Edinburgh
Verified
Journal Article
Open access
SNSUBRAMANIAN NALLASIVAN
SUBRAMANIAN NALLASIVAN
TGT Gillott
T Gillott
SKS Kamath
S Kamath
LBL Blow
L Blow
VGV Goddard
V Goddard
Record Keeping Standards is a development led by the Royal College of Physicians of London (RCP) Health Informatics Unit and funded by the National Health Service (NHS) Connecting for Health. A supplementary report produced by the RCP makes a number of recommendations based on a study held at an acute hospital trust. We audited the medical notes and coding to assess the accuracy, documentation by the junior doctors and also to correlate our findings with the RCP audit. Northern Lincolnshire &Goole Hospitals NHS Foundation Trust has 114,000 ‘finished consultant episodes’ per year. A total of 100 consecutive medical (50) and rheumatology (50) discharges from Diana Princess of Wales Hospital from August–October 2009 were reviewed. The results showed an improvement in coding accuracy (10% errors), comparable to the RCP audit but with 5% documentation errors. Physician involvement needs enhancing to improve the effectiveness and to ensure clinical safety.

1 March 2019 in Indian Journal of Rheumatology
Verified
Journal Article
Open access
SNSUBRAMANIAN NALLASIVAN
SUBRAMANIAN NALLASIVAN
Osteoporosis is ever increasing as life expectancy continues to increase across the world. Hypovitaminosis D has been found to be prevalent even in children and adults, and hence, it is imperative to educate the public on the nutrition for bone health. “Love your bones and joints” was the slogan by the World Health Organization to increase the awareness among the public. Bone density is assessed by Dual Energy X-ray Absorptiometry scan and the T score system. Although biomarkers have been studied in research, their clinical utility is still elusive. Regular exercise and adequate intake of Calcium and Vitamin D are important to maintain bone health. Bisphosphonates are the first line drugs in the management of osteoporosis both for primary and secondary prophylaxis. Second-line drugs include denosumab, teriparatide, and newer drugs such as abaloparatide, romosozumab, and calcitonin, which have found more real-life acceptance and efficacious in the long-term management of osteoporosis. Romosozumab, a monoclonal antibody may well become the ideal osteoporosis drug with effects on bone formation and resorption. Surgical treatment choices include – Vertebroplasty and kyphoplasty are being accepted in specific instances and selected centers with variable success.

6 November 2025 in BMC Rheumatology
Verified
Journal Article
Open access
PDF file
VSVineeta Shobha
Vineeta Shobha
KKKriti Kishor
Kriti Kishor
CGChanchal Gera
Chanchal Gera
VNV. Nayana
V. Nayana
SRSmruti Ramteke
Smruti Ramteke
AAAmita Aggarwal
Amita Aggarwal
We estimated the frequency of catastrophic healthcare expenditure(CHE), and their determinants in Indian patients with systemic lupus erythematosus(SLE). This was a cross-sectional, questionnaire-based survey conducted by the Lupus Special Interest Group of the Indian Rheumatology Association across 14 centers. Patients with SLE diagnosed as per SLICC-2012 on follow-up for at least 1-year were interviewed regarding annual disease-related expenditures including direct (medical and non-medical) and indirect costs. CHE was defined as > 20% of the annual income. Results are presented in Indian currency (INR), wherein 100 INR = 1.19 USD = 1.1 EURO. We included 655 patients with SLE [92.7% women], with a mean age of 32.9 ± 11.6 years. The median direct annual expenditure was INR 52400(30810,96300), largest component being cost of medications [INR 24000(12000,40000) and hospitalizations [INR 35000(14400,90000)] One-third of patients(n = 237,36.2%) suffered CHE; they were older [AOR1.01(0.99,1.03)], had lower level of education [AOR1.95(1.01,3.81)], belonged to lower socio-economic-strata[AOR 9.63(5.66,16.4)], had renal and/or neuropsychiatric lupus [AOR1.42(0.99,2.06)] and higher damage(SDI) [AOR1.84(1.22,2.77)]. The median annual indirect cost was INR16416(5016,52896). Three-fourths(73.7%) of the participants incurred out-of-pocket expenses for their healthcare. The employed population was low(n = 187;28.3%), and the absenteeism rate was 24%. Hospitalization and medication costs are major factors driving exponentially high out-of-pocket expenses, resulting in CHE in one-third of patients with SLE in India. Not applicable.

1 May 2023 in Indian Journal of Rheumatology
Verified
Journal Article
Closed access
TBTrupti Bodhare
Trupti Bodhare
SBSamir Bele
Samir Bele
SNSUBRAMANIAN NALLASIVAN
SUBRAMANIAN NALLASIVAN
JAJ. Vijay Anto
J. Vijay Anto
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic Society